(19)
(11) EP 1 165 752 A2

(12)

(88) Date of publication A3:
18.10.2001

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00975335.1

(22) Date of filing: 21.10.2000
(51) International Patent Classification (IPC)7C12N 5/00, C12N 15/00, C12N 15/09, C12N 15/63, C07K 1/00, C07K 14/00, C07K 17/00
(86) International application number:
PCT/US0029/151
(87) International publication number:
WO 0130/966 (03.05.2001 Gazette 2001/18)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 22.10.1999 US 161186 P

(71) Applicant: ALEXION PHARMACEUTICALS, INC.
New Haven, CT 06511 (US)

(72) Inventors:
  • FODOR, William, L.
    Madison, CT 06443 (US)
  • PIZZOLATO, Maryellen
    Old Saybrook, CT 06475 (US)

(74) Representative: Maschio, Antonio 
D Young & Co, 21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) AN ENGINEERED RECOMBINANT MOLECULE THAT REGULATES HUMORAL AND CELLULAR EFFECTOR FUNCTIONS OF THE IMMUNE SYSTEM